Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicinal composition with glycosamine hydrochloride and cartilagin sulfate as active components, its preparation and use thereof

A technology of glucosamine hydrochloride and chondroitin sulfate, applied in the field of medicine, can solve problems such as prolonged bleeding time

Inactive Publication Date: 2006-08-16
FUKANGREN BIO PHARMA
View PDF0 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Early first-line drugs for the treatment of osteoarthritis include: paracetamol, topical analgesics, and non-steroidal anti-inflammatory drugs. The use of these drugs is accompanied by serious side effects—corresponding effects of gastric ulcer, IIR functional impairment, and prolonged bleeding time. appear, and NSAIDs only relieve the symptoms of patients with osteoarthritis, but cannot change the development of their lesions

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] Example 1 Glucosamine Hydrochloride and Chondroitin Sulfate Tablets

[0018] components

Dosage

Glucosamine Hydrochloride

Chondroitin Sulfate

sucrose

Starch slurry (calculated as starch)

Co-made

500g

400g

82g

18g

1000 pieces

[0019] Preparation:

[0020] Pass glucosamine hydrochloride, chondroitin sulfate, and sucrose through 80-mesh sieve respectively, after mixing evenly, add 4% starch slurry to make soft material, granulate with 18-mesh sieve, dry, granulate with 16-mesh sieve, and press with suitable die after mixing evenly Tablets, ready to serve.

Embodiment 2

[0021] Embodiment 2: Glucosamine hydrochloride and chondroitin sulfate capsules

[0022] components

Dosage

Glucosamine Hydrochloride

Chondroitin Sulfate

microcrystalline cellulose

Magnesium stearate

Co-made

250g

200g

20g

Appropriate amount

1000 capsules

[0023] Preparation:

[0024] Pass glucosamine hydrochloride, chondroitin sulfate and microcrystalline cellulose through 80-mesh sieve respectively, mix uniformly, add prescribed amount of magnesium stearate, mix uniformly and pack into suitable capsule shells to obtain the product.

Embodiment 3

[0025] Example 3: Glucosamine Hydrochloride and Chondroitin Sulfate Chewable Tablets

[0026] components

Dosage

Glucosamine Hydrochloride

Chondroitin Sulfate

Xylitol

Menthol

500g

400g

143g

15g

Sweet Orange Flavor

aspartame

50% ethanol solution

Magnesium stearate

Co-made

20g

12g

Appropriate amount

10g

1000 pieces

[0027] Preparation:

[0028] Pass glucosamine hydrochloride, chondroitin sulfate, xylitol, sweet orange essence, and aspartame through 80 mesh sieve respectively, after mixing evenly, add 50% ethanol solution to make soft material, granulate with 16 mesh sieve, dry, 12 Mesh sieve for granulation, add menthol and magnesium stearate, mix evenly, and press into tablets to obtain the product.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A medicinal composition in the form of tablet, capsule, dispersing tablet, effervescent tablet, etc for treating the various osteoarthritides is prepared from aminoglucose hydrochloride, chondroitin sulfate and pharmacologically acceptable additives.

Description

technical field [0001] The invention relates to a pharmaceutical composition with glucosamine hydrochloride and chondroitin sulfate as active components, a preparation method and application thereof, and belongs to the technical field of medicine. Background technique [0002] Osteoarthritis is a degenerative chronic joint disease. The clinical manifestations are pain, swelling, and limited movement of the affected joints. In advanced patients, symptoms and signs such as cartilage spalling, bone spur formation, and subchondral osteonecrosis may appear, resulting in loss of joint function. , Severe cases must undergo artificial joint conversion surgery. [0003] Osteoarthritis is a major disease that causes functional disability, economic loss, and social development in people over the age of 50. my country's epidemiological survey shows that the population prevalence of osteoarthritis is 9.6%, and the estimated incidence is related to age. Among the population over 65 years...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/7008A61K31/737A61K9/20A61K9/46A61K9/48A61P19/02
Inventor 严轶东
Owner FUKANGREN BIO PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products